ARTICLE | Finance
Next Phase for Karolinksa
Biotech investor Karolinska readying IPO on NASDAQ OMX Stockholm
April 4, 2011 7:00 AM UTC
Early stage biotech investor Karolinska Developmentis looking to go public to enable it to support its portfolio through early 2014. By then, it expects to see enough M&A, IPO and partnership activity to be cash flow positive.
Karolinska last week filed to raise SEK421.8-SEK478.8 million ($66-$74.9 million) through the sale of up to 11.4 million shares at SEK37-SEK42 in an IPO on NASDAQ OMX Stockholm...